Year: 2017
Type: review
Abstract: Amyotrophic lateral sclerosis (ALS) and spinal and bulbar muscular atrophy (SBMA) are two motoneuron diseases (MNDs) characterized by aberrant protein behavior in affected cells. In familial ALS (fALS) and in SBMA specific gene mutations lead to the production of neurotoxic proteins or peptides prone to misfold, which then accumulate in form of aggregates. Notably, some of these proteins accumulate into aggregates also in sporadic ALS (sALS) even if not mutated. To prevent proteotoxic stresses detrimental to cells, misfolded and/or aggregated proteins must be rapidly removed by the protein quality control (PQC) system. The small heat shock protein B8 (HSPB8) is a chaperone induced by harmful events, like proteasome inhibition. HSPB8 is expressed both in motoneuron and muscle cells, which are both targets of misfolded protein toxicity in MNDs. In ALS mice models, in presence of the mutant proteins, HSPB8 is upregulated both in spinal cord and muscle. HSPB8 interacts with the HSP70 co-chaperone BAG3 and enhances the degradation of misfolded proteins linked to sALS, or causative of fALS and of SBMA. HSPB8 acts by facilitating autophagy, thereby preventing misfolded protein accumulation in affected cells. BAG3 and BAG1 compete for HSP70-bound clients and target them for disposal to the autophagy or proteasome, respectively. Enhancing the selective targeting of misfolded proteins by HSPB8-BAG3-HSP70 to autophagy may also decrease their delivery to the proteasome by the BAG1-HSP70 complex, thereby limiting possible proteasome overwhelming. Thus, approaches aimed at potentiating HSPB8-BAG3 may contribute to the maintenance of proteostasis and may delay MNDs progression.
Language: English
Topic: Heat shock proteins research
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,240
Funders: European Molecular Biology Organization, Association Française contre les Myopathies, Università degli Studi di Milano, EU Joint Programme – Neurodegenerative Disease Research, European Commission, Fondazione Telethon, Fondazione Cariplo, Ministero della Salute, Ministero dell’Istruzione, dell’Università e della Ricerca, Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica, Regione Lombardia, Fondazione Regionale per la Ricerca Biomedica, Hsinchu Science Park Bureau, Ministry of Science and Technology, Taiwan
Awards: G1520323463, G2269122737, G2817920283, G297937679, G3156888303, From RNA to Protein toxicity in motorneuron diseases, G4249929771, G434337789, G458924178, G4876879314, G493698437, RAN-translation of normal and expanded nucleotide repeat containing transcripts to neurotoxic polypetides in neurodegenerative diseases, G5171413337, G5382016613, G596092256, G6215711124, G6865116617, G712116886, G7155227525, G7591890595, G8563002755, ERA-NET for establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020, G896540024, G917473516
OpenAlex ID: W2637049113
